Active Watch List: BioAmber Inc. (NYSE:BIOA), Lumber Liquidators Holdings, Inc. (NYSE:LL), Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), RGC Resources, Inc. (NASDAQ:RGCO), Telefonica (NYSE:TEF)

BioAmber Inc. (NYSE:BIOA) has released financial results for the second quarter, reporting construction was completed on its first commercial-scale bio-succinic acid plant in June. That facility, located in Sarnia, Ontario, is currently undergoing commissioning, with commercial operations expected to begin this quarter. Completing construction was a major milestone for the company,” said Jean-Francois Huc, CEO of BioAmber. “Commissioning is progressing well and we expect to be in commercial operation this quarter. We are seeing an acceleration of bio-succinic acid’s use in polyurethanes, paints and coatings, with a growing number of customer product launches coinciding with our Sarnia plant coming into production. BioAmber Inc. (NYSE:BIOA) belongs to Basic Materials sector. Its weekly performance is -13.94%. On last trading day company shares ended up $5.99. BioAmber Inc. (NYSE:BIOA) distance from 50-day simple moving average (SMA50) is -26.23%.

Lumber Liquidators Holdings, Inc. (NYSE:LL) reported a second-quarter loss as its struggles over imported Chinese-made products persist. The flooring retailer said it was unable to provide an outlook for the full year and its shares tumbled 28 percent Wednesday to a multiyear low. Lumber Liquidators Holdings, Inc. (NYSE:LL) shares moved down -27.72% in last trading session and ended the day at $13.27. LL Gross Margin is 38.50% and its return on assets is 8.80%. Lumber Liquidators Holdings, Inc. (NYSE:LL) quarterly performance is -51.27%.

Portola Pharmaceuticals (Nasdaq:PTLA) provided a corporate update and reported its financial results for the second quarter ended June 30, 2015.We continue to make solid progress toward near-term significant milestones that will allow us to launch two of our late-stage thrombosis products that target multi-billion dollar hospital-based markets – andexanet alfa in 2016 and betrixaban in 2017. On 05 August, Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) shares moved down -2.01% and was closed at $50.27. PTLA EPS growth in last 5 year was 0.00%. Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) year to date (YTD) performance is 77.51%.

RGC Resources, Inc. (NASDAQ:RGCO) announced consolidated Company earnings of $354,940 or $0.08 per average share outstanding for the quarter ended June 30, 2015. This compares to consolidated earnings of $283,194 or $0.06 per average share outstanding for the quarter ended June 30, 2014. CFO Paul Nester attributed the increase in earnings to improved utility margins from modest customer growth and lower interest expense.RGC Resources, Inc. (NASDAQ:RGCO) ended the last trading day at $20.06. Company weekly volatility is calculated as 2.13% and price to cash ratio as 105.43. RGC Resources, Inc. (NASDAQ:RGCO) showed a weekly performance of -0.30%.

French media company Vivendi SA sold a 4 percent stake in Telefonica S.A. (ADR) (NYSE:TEF) Brazilian unit for $877 million to complete its retreat from the South American nation.Along with the conversion of another 3.5 percent holding in Telefonica Brasil SA into a 0.97 percent stake in Madrid-based Telefonica, Vivendi will no longer own stock in the Brazilian mobile-phone company, it said in a statement Thursday. Vivendi had received the Telefonica Brasil shares as payment for the disposal its broadband unit GVT to Telefonica, which was completed this year. Telefonica S.A. (ADR) (NYSE:TEF) shares moved up 1.25% in last trading session and ended the day at $15.38. TEF Gross Margin is 70.00% and its return on assets is 3.80%. Telefonica S.A. (ADR) (NYSE:TEF) quarterly performance is 4.53%.

Leave a Reply

Your email address will not be published. Required fields are marked *